Lista de obras - Andreas Engert - Dominio Público Uruguay

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

scientific journal article

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patients

artículo científico publicado en 2013

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

artículo científico publicado en 2015

Aerobic physical exercise for adult patients with haematological malignancies

artículo científico publicado en 2014

Alemtuzumab for chronic lymphocytic leukaemia

artículo científico publicado en 2009

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma

artículo científico publicado en 2010

Antibiotics for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

artículo científico publicado en 2016

Antibiotics plus colony stimulating factors versus CSFs alone and antibiotics plus CSFs versus no prophylaxis for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

artículo científico publicado en 2009

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

artículo científico publicado en 2012

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

artículo científico publicado en 2011

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

artículo científico publicado en 2009

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies

artículo científico publicado en 2011

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies

artículo científico publicado en 2004

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

artículo científico publicado en 2011

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

artículo científico publicado en 2007

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

artículo científico publicado en 2009

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin Lymphoma

artículo científico publicado en 2008

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

artículo científico publicado en 2011

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2007

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

artículo científico publicado en 2011

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

artículo científico publicado en 2009

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation

artículo científico publicado en 2008

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

scientific journal article

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

artículo científico publicado en 2012

Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (APL))

artículo científico publicado en 2015

Erythropoietin or Darbepoetin for patients with cancer

artículo científico publicado en 2006

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

artículo científico publicado en 2009

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

artículo científico publicado en 2008

Erythropoietin or darbepoetin for patients with cancer

artículo científico publicado en 2012

First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2008

First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia

artículo científico publicado en 2007

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies ⬇️

artículo científico publicado el 17 de octubre de 2012

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2016

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2011

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

artículo científico publicado en 2008

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

artículo científico publicado en 2013

High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients

artículo científico publicado en 2011

High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data

artículo científico publicado en 2009

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

artículo científico publicado en 2008

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

artículo científico publicado en 2012

Hypomethylating agents for adult patients with acute myeloid leukaemia

artículo científico publicado en 2016

Hypomethylating agents for adult patients with acute myeloid leukaemia

artículo científico publicado en 2011

Hypomethylating agents for patients with myelodysplastic syndrome

artículo científico publicado en 2016

Hypomethylating agents for patients with myelodysplastic syndrome

artículo científico publicado en 2011

Idiotype vaccination for Non-Hodgkin lymphoma

artículo científico publicado en 2016

Idiotype vaccination for Non-Hodgkin lymphoma

artículo científico publicado en 2011

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers

artículo científico publicado en 2016

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers

artículo científico publicado en 2011

Low dose cytarabine monotherapy for acute myeloid leukaemia

artículo científico publicado en 2016

Low dose cytarabine monotherapy for acute myeloid leukaemia

artículo científico publicado en 2011

Low dose cytarabine monotherapy for myelodysplastic syndromes

artículo científico publicado en 2011

Meditation for adult patients with haematological malignancies

artículo científico publicado en 2014

Mindfulness-based stress reduction for women diagnosed with breast cancer

artículo científico publicado en 2015

Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

artículo científico publicado en 2009

Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

artículo científico publicado en 2009

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival

artículo científico publicado en 2010

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

artículo científico publicado en 2013

Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma

artículo científico publicado en 2015

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy

artículo científico publicado en 2015

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy

artículo científico publicado en 2009

Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia

artículo científico publicado en 2012

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

artículo científico publicado en 2012

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

artículo científico publicado en 2011

Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors

artículo científico publicado en 2017

The European Hematology Association Roadmap for European Hematology Research: a consensus document

artículo científico publicado en 2016

The role of additional radiotherapy for primary central nervous system lymphoma (PCNSL)

artículo científico publicado en 2011

The role of physical exercise for adult patients with haematological malignancies

artículo científico publicado en 2011

Thrombopoietin mimetics for patients with myelodysplastic syndromes

artículo científico publicado en 2012

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma

scientific journal article

Yoga for haematological malignancies

artículo científico publicado en 2012

Yoga in addition to standard care for patients with haematological malignancies

artículo científico publicado en 2014

Lista de obras de Andreas Engert

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patients

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

Aerobic physical exercise for adult patients with haematological malignancies

Alemtuzumab for chronic lymphocytic leukaemia

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma

Antibiotics for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

Antibiotics plus colony stimulating factors versus CSFs alone and antibiotics plus CSFs versus no prophylaxis for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies

Antiviral agents for prophylaxis of herpesviridae infections in patients with haematological malignancies

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin Lymphoma

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (APL))

Erythropoietin or Darbepoetin for patients with cancer

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

Erythropoietin or darbepoetin for patients with cancer

First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma

First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies ⬇️

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients

High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

Hypomethylating agents for adult patients with acute myeloid leukaemia

Hypomethylating agents for adult patients with acute myeloid leukaemia

Hypomethylating agents for patients with myelodysplastic syndrome

Hypomethylating agents for patients with myelodysplastic syndrome

Idiotype vaccination for Non-Hodgkin lymphoma

Idiotype vaccination for Non-Hodgkin lymphoma

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers

Low dose cytarabine monotherapy for acute myeloid leukaemia

Low dose cytarabine monotherapy for acute myeloid leukaemia

Low dose cytarabine monotherapy for myelodysplastic syndromes

Meditation for adult patients with haematological malignancies

Mindfulness-based stress reduction for women diagnosed with breast cancer

Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy

Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors

The European Hematology Association Roadmap for European Hematology Research: a consensus document

The role of additional radiotherapy for primary central nervous system lymphoma (PCNSL)

The role of physical exercise for adult patients with haematological malignancies

Thrombopoietin mimetics for patients with myelodysplastic syndromes

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma

Yoga for haematological malignancies

Yoga in addition to standard care for patients with haematological malignancies